Already a member? Sign in
Category: Prescription Drugs
Most Popular Types: Vasotec, Pharmagenus
See also: Corodil Comp
Enalapril is an angiotensin-converting enzyme (ACE) inhibitor used to treat hypertension, heart failure and dysfunction. Off label it is used to delay the progression of renal disease and reduce risk of cardiac events in hypertensive diabetics.
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| Elevated blood pressure | 44 | 8 |
|
|
|
||
| Hypertension | 34 | 3 |
|
||||
| Other | 12 | 2 |
|
||||
| Kidney disease (chronic) | 3 | 1 |
|
||||
| Increase effect of another treatment | 3 | 1 |
|
||||
| General health | 3 | 2 |
|
See all 101 patients currently taking Enalapril
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Enalapril
| Dizziness | 2 | |
|---|---|---|
| Low blood pressure | 1 | |
| Dizziness with hypotension upon standing | 1 | |
| High blood pressure increased | 1 | |
| Stomach ache | 1 | |
| Hyperkalemia | 1 |
Frequently reported dosages based on patients currently taking Enalapril. See all 11 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Doctor's advice | 12 | ||
| Other | 5 | ||
| Side effects too severe | 3 | ||
| Did not seem to work | 2 | ||
| Expense | 1 | ||
| Course of treatment ended | 1 | ||
| Change in health plan coverage | 1 |
Adherence
Taking treatment as prescribed
Adherence of Enalapril
Always |
16 | 89% |
|
|---|---|---|---|
Usually |
1 | 6% |
|
Sometimes |
0 | 0% |
|
Never |
1 | 6% |
|
Burden
Difficulty being on treatment
Burden of Enalapril
Very |
0 | 0% |
|
|---|---|---|---|
Somewhat |
0 | 0% |
|
A little |
2 | 11% |
|
Not at all |
16 | 89% |
|
Cost
Paid out of pocket
Cost of Enalapril
$200+ |
0 | 0% |
|
|---|---|---|---|
$100-199 |
0 | 0% |
|
$50-99 |
0 | 0% |
|
$25-49 |
0 | 0% |
|
< $25 |
9 | 100% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on May 25, 2012.